Cargando…

PBPK model reporting template for chemical risk assessment applications

Physiologically-based pharmacokinetic (PBPK) modeling analysis does not stand on its own for regulatory purposes but is a robust tool to support drug/chemical safety assessment. While the development of PBPK models have grown steadily since their emergence, only a handful of models have been accepte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Yu-Mei, Chan, Melissa, Chukwudebe, Amechi, Domoradzki, Jeanne, Fisher, Jeffrey, Hack, C. Eric, Hinderliter, Paul, Hirasawa, Kota, Leonard, Jeremy, Lumen, Annie, Paini, Alicia, Qian, Hua, Ruiz, Patricia, Wambaugh, John, Zhang, Fagen, Embry, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188465/ https://www.ncbi.nlm.nih.gov/pubmed/32502513 http://dx.doi.org/10.1016/j.yrtph.2020.104691

Ejemplares similares

Capturing the applicability of in vitro-in silico membrane transporter data in chemical risk assessment and biomedical research
por: Clerbaux, Laure-Alix, et al.
Publicado: (2018)

Membrane transporter data to support kinetically-informed chemical risk assessment using non-animal methods: Scientific and regulatory perspectives
por: Clerbaux, Laure-Alix, et al.
Publicado: (2019)

PBPK Model for Atrazine and Its Chlorotriazine Metabolites in Rat and Human
por: Campbell, Jerry L., et al.
Publicado: (2016)

Development, Testing, Parameterisation and Calibration of a Human PBPK Model for the Plasticiser, Di-(2-propylheptyl) Phthalate (DPHP) Using in Silico, in vitro and Human Biomonitoring Data
por: McNally, Kevin, et al.
Publicado: (2021)

An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
por: Fairman, Kiara, et al.
Publicado: (2023)

Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model
por: Kuepfer, L, et al.
Publicado: (2016)

Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment
por: Najjar, Abdulkarim, et al.
Publicado: (2022)

Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment
por: Tan, Yu-Mei, et al.
Publicado: (2021)

Proposed PBPK Model to Predict Infant Exposure to Toxic Chemicals in Breast Milk
por: Soldin, OP
Publicado: (2002)

Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure.
por: Clewell, Rebecca A, et al.
Publicado: (2002)

Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans
por: Mallick, Pankajini, et al.
Publicado: (2020)

Chemical templates
por: Höger, Sigurd
Publicado: (2014)

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK
por: Wagner, C, et al.
Publicado: (2015)

Development of a Human Physiologically Based Pharmacokinetic (PBPK) Toolkit for Environmental Pollutants
por: Ruiz, Patricia, et al.
Publicado: (2011)

Ultrasensitive analysis of genetic instability related to chemical exposure
por: Domoradzki, Tomasz, et al.
Publicado: (2021)

PBPK modeling and simulation in drug research and development
por: Zhuang, Xiaomei, et al.
Publicado: (2016)

Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them
por: Peters, Sheila Annie, et al.
Publicado: (2019)

A Workflow for Global Sensitivity Analysis of PBPK Models
por: McNally, Kevin, et al.
Publicado: (2011)

PBPK Modeling on Organs-on-Chips: An Overview of Recent Advancements
por: Yang, Yi, et al.
Publicado: (2022)

Permeability of Gemcitabine and PBPK Modeling to Assess Oral Administration
por: Ferreira, Abigail, et al.
Publicado: (2021)

The Role of “Physiologically Based Pharmacokinetic Model (PBPK)” New Approach Methodology (NAM) in Pharmaceuticals and Environmental Chemical Risk Assessment
por: Deepika, Deepika, et al.
Publicado: (2023)

SimRFlow: An R-based workflow for automated high-throughput PBPK simulation with the Simcyp(®) simulator
por: Khalidi, Hiba, et al.
Publicado: (2022)

Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications
por: Paini, Alicia, et al.
Publicado: (2017)

Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
por: Jamei, Masoud
Publicado: (2020)

Current PBPK Models: Are They Predicting Tissue Drug Concentration Correctly?
por: Ibarra, Manuel, et al.
Publicado: (2020)

PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease
por: Montanha, Maiara Camotti, et al.
Publicado: (2022)

PKQuest: PBPK modeling of highly lipid soluble and extracellular solutes
por: Levitt, David G.
Publicado: (2018)

Complex Mixtures: Array PBPK Modeling of Jet Fuel Components
por: Sterner, Teresa R., et al.
Publicado: (2023)

Development and application of a PBPK modeling strategy to support antimalarial drug development
por: Abla, Nada, et al.
Publicado: (2023)

Translatability and transferability of in silico models: Context of use switching to predict the effects of environmental chemicals on the immune system
por: Pappalardo, Francesco, et al.
Publicado: (2022)

Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype‐Guided Dosing of Tamoxifen
por: Nakamura, Toshimichi, et al.
Publicado: (2018)

Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
por: Frechen, Sebastian, et al.
Publicado: (2022)

Exposure Forecasting – ExpoCast – for Data-Poor Chemicals in Commerce and the Environment
por: Wambaugh, John F., et al.
Publicado: (2022)

Role of Physiologically Based Kinetic modelling in addressing environmental chemical mixtures – A review
por: Desalegn, Anteneh, et al.
Publicado: (2019)

Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics.
por: Bois, F Y
Publicado: (2000)

Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics.
por: Bois, F Y
Publicado: (2000)

Physiologically Based Pharmacokinetic (PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats
por: Cuello, W. S., et al.
Publicado: (2012)

PBPK-Based Probabilistic Risk Assessment for Total Chlorotriazines in Drinking Water
por: Breckenridge, Charles B., et al.
Publicado: (2016)

Analysis of biomarker utility using a PBPK/PD model for carbaryl
por: Phillips, Martin B., et al.
Publicado: (2014)

Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
por: Utembe, Wells, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k8fh9vbfoj9pd77hrm8296i5be